ADVISORY/InforMax, Inc. Invites You to Join Its 2001 Third Quarter Preliminary Results.

Business Editors/Hi-Tech Writers

BIOWIRE2K

ADVISORY...Tuesday (Oct. 16)

--(BW HealthWire)

You are invited to listen to the InforMax, Inc. (Nasdaq:INMX) 2001 Third Quarter Preliminary Results Conference Call which will be broadcast live over the Internet on Tuesday, October 16, 2001, at 8:45 A.M. Eastern Time.

What:             InforMax, Inc. 2001 Third Quarter Preliminary
                  Results Conference Call

When:             8:45 a.m. Eastern Time, Tuesday, October 16, 2001

Where:            Bethesda, MD

How:              Live Call
                  Domestic dial-in: [phone]
                  International dial-in: [phone]
                  Confirmation/access: 2112181

                  Live on the Internet-
                  Please click on Investor Relations at
                  www.informaxinc.com

Contact:          Rachel Garcia
                  Manager, Investor Relations
                  [phone]

Playback:         Domestic dial-in: [phone]
                  International dial-in: [phone]
                  Confirmation/access: 2112181

                  Webcast Playback-
                  Please click on Investor Relations at
                  www.informaxinc.com

InforMax is the leading global developer of bioinformatics software for High-Throughput Research(TM). Founded in 1990, InforMax products are used by over 1,800 research organizations and more than 28,000 individual scientists worldwide (as of September 30, 2001) to understand and extract value from the massive amounts of data being generated by the Genomic Revolution.

Among InforMax's customers are 23 of the top 25 pharmaceutical companies. InforMax's mission is to support the scientific community in drug discovery and to better understand the causes of disease. Our comprehensive portfolio of bioinformatics software solutions help scientists increase the effectiveness and reduce the time and investment it takes to identify and validate biological targets and discover treatments for disease. InforMax bioinformatics software solutions enable a full range of gene-to-genome analysis, interpretation and data mining.

Our market-leading products include Vector NTI(R) Suite, the most widely used software suite for enhancing laboratory productivity, and GenoMax(TM), a modular family of analysis programs for integrated analysis of genomic and proteomic data. Additional information about InforMax can be found at our Web site at http://www.informaxinc.com.